<table border="single" id="id_e48115e6-39f4-4e3c-8ad1-ed4b8660df25" width="478.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_c7d2aecb-aead-40ef-a29a-b9b2e7f73497"> Table 11: Results of Drug Interaction Studies with Buffered Formulations of Didanosine: Effects of Coadministered Drug of Didanosine Plasma AUC and C<sub>max </sub>Values</caption>
<col width="34.5%"></col>
<col width="24.7%"></col>
<col width="8.4%"></col>
<col width="16.5%"></col>
<col width="15.9%"></col>
<tbody>
<tr id="id_d7f09dbb-7c1d-4615-a51a-3bf6b28a9357">
<td align="left" colspan="3" stylecode="Toprule" valign="top"></td>
<td align="center" colspan="2" stylecode="Botrule" valign="top">
<paragraph>
<content stylecode="bold">% Change of Didanosine</content>
</paragraph>
<content stylecode="bold">Pharmacokinetic Parameters
                                    </content>
</td>
</tr>
<tr id="id_1b76a04a-a431-4f0e-8d01-bfc4998b41b0">
<td align="center" colspan="3" stylecode="Botrule" valign="top">
<content stylecode="bold"> Drug Didanosine Dosage n </content>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>
<content stylecode="bold">AUC of Didanosine</content>
</paragraph>
<content stylecode="bold">(95% CI)</content>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>
<content stylecode="bold">C<sub>max</sub> of Didanosine</content>
</paragraph>
<content stylecode="bold">(95% CI)</content>
</td>
</tr>
<tr id="id_496788c6-d2ac-432c-98bf-83ce78b04d90">
<td align="left" stylecode="Botrule" valign="top">
<paragraph>allopurinol,</paragraph>
<paragraph>renally impaired, 300 mg/day</paragraph>
<paragraph>healthy volunteer, 300 mg/day for 7 days</paragraph>
<paragraph>ganciclovir, 1000 mg every <br/>8 hours, 2 hours after didanosine</paragraph>
<paragraph>ciprofloxacin, 750 mg every <br/>12 hours for 3 days, 2 hours before didanosine </paragraph>
<paragraph>indinavir, 800 mg single dose simultaneous</paragraph>
<paragraph> 1 hour before didanosine</paragraph>
<paragraph>ketoconazole, 200 mg/day for <br/>4 days, 2 hours before didanosine</paragraph>
<paragraph>loperamide, 4 mg every 6 hours for 1 day</paragraph>
<paragraph>metoclopramide, 10 mg single dose</paragraph>
<paragraph>ranitidine, 150 mg single dose, <br/>2 hours before didanosine</paragraph>
<paragraph>rifabutin, 300 mg or 600 mg/day for <br/>12 days</paragraph>
<paragraph>ritonavir, 600 mg every 12 hours for 4 days</paragraph>
<paragraph>stavudine, 40 mg every 12 hours for 4 days</paragraph>
<paragraph>sulfamethoxazole, 1000 mg single dose</paragraph>
<paragraph>trimethoprim, 200 mg single dose</paragraph>
<paragraph>zidovudine, 200 mg every 8 hours for 3 days</paragraph>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>200 mg single dose</paragraph>
<paragraph>400 mg single dose</paragraph>
<paragraph>200 mg every</paragraph>
<paragraph>12 hours</paragraph>
<paragraph>200 mg every</paragraph>
<paragraph>12 hours for 3 days</paragraph>
<paragraph>200 mg single dose</paragraph>
<paragraph>200 mg single dose</paragraph>
<paragraph>375 mg every </paragraph>
<paragraph>12 hours for 4 days</paragraph>
<paragraph>300 mg single dose</paragraph>
<paragraph>300 mg single dose</paragraph>
<paragraph>375 mg single dose</paragraph>
<paragraph>167 mg or 250 mg every 12 hours for 12 days</paragraph>
<paragraph>200 mg every 12 hours for 4 days</paragraph>
<paragraph>100 mg every 12 hours for 4 days</paragraph>
<paragraph>200 mg single dose</paragraph>
<paragraph>200 mg single dose</paragraph>
<paragraph>200 mg every</paragraph>12 hours for 3 days</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>2</paragraph>
<paragraph>14</paragraph>
<paragraph>12</paragraph>
<paragraph>8<footnote id="id-e264e408-de0c-42f4-98e5-8b2b82209ebf">HIV-infected patients.</footnote>
</paragraph>
<paragraph>16</paragraph>
<paragraph>16</paragraph>
<paragraph>12<footnoteref idref="id-e264e408-de0c-42f4-98e5-8b2b82209ebf"></footnoteref>
</paragraph>
<paragraph>12<footnoteref idref="id-e264e408-de0c-42f4-98e5-8b2b82209ebf"></footnoteref>  </paragraph>
<paragraph>12<footnoteref idref="id-e264e408-de0c-42f4-98e5-8b2b82209ebf"></footnoteref>
</paragraph>
<paragraph>12<footnoteref idref="id-e264e408-de0c-42f4-98e5-8b2b82209ebf"></footnoteref>
</paragraph>
<paragraph>11</paragraph>
<paragraph>12</paragraph>
<paragraph>10</paragraph>
<paragraph>8<footnoteref idref="id-e264e408-de0c-42f4-98e5-8b2b82209ebf"></footnoteref>
</paragraph>
<paragraph>8<footnoteref idref="id-e264e408-de0c-42f4-98e5-8b2b82209ebf"></footnoteref>
</paragraph>
<paragraph>6<footnoteref idref="id-e264e408-de0c-42f4-98e5-8b2b82209ebf"></footnoteref>
</paragraph>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>↑ 312%</paragraph>
<paragraph>↑ 113%</paragraph>
<paragraph>↑ 111%</paragraph>
<paragraph>↓ 16%</paragraph>
<paragraph>↔</paragraph>
<paragraph>↓ 17% </paragraph>
<paragraph>(-27, -7%)<footnote id="id-e14e367c-2d17-448c-9046-6bbaf49c4392">90% CI.</footnote>
</paragraph> ↔ <paragraph>↔</paragraph>
<paragraph>↔</paragraph>
<paragraph>↑ 14%</paragraph>
<paragraph>↑ 13% </paragraph>
<paragraph>(-1, 27%)</paragraph>
<paragraph>↓ 13% </paragraph>
<paragraph>(0, 23%)</paragraph>
<paragraph>↔</paragraph>
<paragraph>↔</paragraph>
<paragraph>↔</paragraph>
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>↑ 232%</paragraph>
<paragraph>↑ 69%</paragraph>
<paragraph>NA</paragraph>
<paragraph>↓ 28%</paragraph>
<paragraph>↔</paragraph>
<paragraph>↓ 13% </paragraph>
<paragraph>(-28, 5%)<footnoteref idref="id-e14e367c-2d17-448c-9046-6bbaf49c4392"></footnoteref>
</paragraph>
<paragraph>↓ 12%</paragraph>
<paragraph>↓ 23%</paragraph>
<paragraph>↑ 13%</paragraph>
<paragraph>↑ 13%</paragraph>
<paragraph>↑ 17% </paragraph>
<paragraph>(-4, 38%)</paragraph>
<paragraph>↓ 16% </paragraph>
<paragraph>(5, 26%)</paragraph>
<paragraph>↔</paragraph>
<paragraph>↔</paragraph>
<paragraph>↑ 17%</paragraph>
<paragraph>(-23, 77%)</paragraph>↔ </td>
</tr>
<tr id="id_ba35e726-eaed-4ee9-be7c-a79971e9f639">
<td align="left" colspan="5" stylecode="Lrule Botrule" valign="top">↑ Indicates increase.<br/>↓ Indicates decrease.<br/>↔ Indicates no change, or mean increase or decrease of less than 10%.</td>
</tr>
</tbody>
</table>